enfortumab vedotin,cisplatin,pembrolizumab
merck,astellas,seagen
['cisplatin', 'ev-103', ' ev ', 'pembro']
#esmo22 ev-103 cohort k shows promising activity for 1l ev + pembro in cisplatin-ineligible patients with la/muc
awaiting further results! 
Cancer researcher; Director of GU Cancers @DanaFarber; Prof of Medicine @HarvardMed; ? lover; ??@PanMass
Views are mine.